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Chagas disease began millions of years ago as an enzootic disease of wild animals and started to be trans-
mitted to man accidentally in the form of an anthropozoonosis when man invaded wild ecotopes. Endemic
Chagas disease became established as a zoonosis over the last 200-300 years through forest clearance for
agriculture and livestock rearing and adaptation of triatomines to domestic environments and to man and
domestic animals as a food source. It is estimated that 15 to 16 million people are infected with Trypanosoma
cruzi in Latin America and 75 to 90 million people are exposed to infection. When T. cruzi is transmitted to man
through the feces of triatomines, at bite sites or in mucosa, through blood transfusion or orally through con-
taminated food, it invades the bloodstream and lymphatic system and becomes established in the muscle and
cardiac tissue, the digestive system and phagocytic cells. This causes inflammatory lesions and immune re-
sponses, particularly mediated by CD4+, CD8+, interleukin-2 (IL) and IL-4, with cell and neuron destruction
and fibrosis, and leads to blockage of the cardiac conduction system, arrhythmia, cardiac insufficiency,
aperistalsis, and dilatation of hollow viscera, particularly the esophagus and colon. T. cruzi may also be trans-
mitted from mother to child across the placenta and through the birth canal, thus causing abortion, prematu-
rity, and organic lesions in the fetus. In immunosuppressed individuals, T. cruzi infection may become reacti-
vated such that it spreads as a severe disease causing diffuse myocarditis and lesions of the central nervous
system. Chagas disease is characterized by an acute phase with or without symptoms, and with entry point
signs (inoculation chagoma or Romaña’s sign), fever, adenomegaly, hepatosplenomegaly, and evident para-
sitemia, and an indeterminate chronic phase (asymptomatic, with normal results from electrocardiogram and x-
ray of the heart, esophagus, and colon) or with a cardiac, digestive or cardiac-digestive form. There is great
regional variation in the morbidity due to Chagas disease, and severe cardiac or digestive forms may occur in
10 to 50% of the cases, or the indeterminate form in the other asymptomatic cases, but with positive serology.
Several acute cases have been reported from Amazon region most of them by T. cruzi I, Z3, and a hybrid ZI/Z3.
We conclude this article presenting the ten top Chagas disease needs for the near future.
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Natural history, origin, and distribution of Chagas
disease
The natural history of Chagas disease began millions
of years ago as an enzootic disease of wild animals, which
still persists in enzootic areas like the Amazon region.
When man ventured into the natural ecotopes of the in-
fection, it started to be transmitted accidentally to man as
an anthropozoonosis. As a result of forest clearance for
extensive agriculture and livestock rearing in Latin America
over the last 200 to 300 years, triatomines that were un-
able to feed because of the displacement of wild ani-
mals started to colonize areas around and within human
homes. They have become adapted to this new niche, feed-
ing on human and domestic animals’ blood as a zoonosis.
Trypanosoma cruzi, their reservoirs, and vectors
have existed in nature for millions of years. The primi-
tive trypanosomes were monogenetic parasites of in-
sects that were not bloodsuckers. When these insects
acquired the habit of blood sucking, the trypanosomes
underwent morphological and functional changes such
that they developed undulating membranes and flagella
so that they could circulate in the blood of vertebrates
(Hoare 1972). Triatomines have been known since the
XVI century (Lent & Wygodzinky 1979), but their adap-
tation to home environments is more recent. Although
human infection in 9000-year-old mummies is known
(Afderheide et al. 2004), endemic Chagas disease has
become established through the forest clearance due to
human action over the last two to three centuries (Aragão
1983). It is estimated that 15 to 16 million people are
infected with T. cruzi in Latin America, and 75 to 90
million people are exposed to infection.
Determinants of Chagas infection
Chagas infection, which was initially a wild enzootic
disease, was transformed into an anthropozoonosis when
man invaded the wild ecotope and occupied the physical
space through his predatory action of clearing the for-
ests, displacing the wild animals, and constructing houses
and outhouses that the triatomines could easily adapt to.
Thus, triatomines began to use man as a food source, and
three intercommunicating cycles became established: the
wild, domestic surrounds, and domestic cycles.
Some wild animals like the opossum, one of the long-
est known reservoirs of T. cruzi, may have an important
role in the epidemiology of Chagas infection, since this
mammal circulates from the wild environment to areas
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around homes and even into homes in search of food. As
has been demonstrated, these animals not only carry the
trypomastigote form of T. cruzi in their bloodstream but
also house all forms of the parasite in their scent glands,
and eliminate it from there (Deane et al. 1984). Con-
versely, domestic animals like cats and dogs may invade
the wild environment to hunt, thereby becoming infected
orally and bringing the infection into the home and areas
surrounding the home.
The adaptation of triatomines to human homes, along
with the circulation of T. cruzi among them and wild and
domestic animals, is certainly the most important de-
terminant for establishing human infection. Although
there has been speculation regarding a genetic transfor-
mation leading to this adaptation, it seems primarily to
be the result from the search by triatomines for a new
food source when the original source became scarcer.
Forattini (1980) put hencoops into various ecotopes
outside of domestic environments and clearly demon-
strated this adaptation.
The mechanisms for the adaptation of wild triatomines
to homes and areas surrounding homes have not been
fully clarified. Democritus’ saying is fitting here, as so
well used in the classic book by Jacques Monod “Le
hasard et la nécessité” (Monod 1970): “everything that
exists in the Universe results from chance or necessity”.
In fact, the mechanism for the adaptation of triatomines
to human homes seems to fit in well with this concept:
the notion of chance, when wild triatomines are passively
brought into the home and areas surrounding the home
with the wood for construction and fuel and the palm
leaves for roofing houses and outhouses, or when they
are attracted by the light; or the notion of need, when
man invades the wild ecotope, clears the forest, contracts
his houses and displaces the animals, thereby obliging
triatomines to seek “artificial niches” in homes and ar-
eas surrounding homes, in search of alternative food
sources among humans and domestic animals. Some spe-
cies like Triatoma infestans are today totally domesti-
cated, except in Bolivia, while others like Panstrongylus
megistus, T. brasiliensis, T. sordida and T. pseudo-
maculata in Brazil are ubiquitous: sometimes wild and
sometimes domesticated or semi-domesticated. Fig. 1
shows palm tree habitat of opossum and triatomines
infecteded with T. cruzi invading huts.
For human Chagas infection to occur under natural
conditions, first of all there needs to be contact between
man and infected triatomines. For this, there is a series
of variables regulating the chances of infection, among
which the following can be highlighted: infection rates,
the time interval between biting and defecation, the num-
ber and volume of evacuations per unit of time, the num-
ber of parasites eliminated, the percentage of infecting
forms and their penetration capacity, the intensity of the
pruritus caused during the biting, etc. For example, al-
though some species are domesticated, they live at
greater separations from man, in roof spaces and cel-
lars, like T. rubrofasciata, and feed on domestic ani-
mals, particularly rats, and occasionally on humans. Other
with a higher degree of anthropophilia lives in closer
proximity, for example in the bedroom. The rates of natu-
ral infection of triatomines caused by T. cruzi vary enor-
mously with the species and the closeness of its contact
with the reservoirs for the parasite. Among the domesti-
cated triatomines, usually not more than 5% are infected.
There are also large differences in the time interval be-
tween biting and evacuation according to species, sex,
and evolutive stage of the insect. The pioneering inves-
tigations on North American (Wood 1951) and South
American (Dias 1956, Zeledon et al. 1977) triatomines
found that the percentage of Rhodnius prolixus that
evacuated just after or while sucking ranged from 40 to
62.5%, T. infestans from 10 to 54.4%, R. neglectus from
12 to 50%, P. megistus from zero among males to 40%
among females, T. sordida from zero among nymphs to
23.1% among male adults, and finally none of the nymphs
of T. vitticeps. In an interesting experimental study car-
ried out in our laboratory (Borges-Pereira et al. 1988),
a mean of 140 parasites per defecation during feeding
was found among eight triatomine species infected with
T. cruzi. The percentage of positive defecations was
55.1% (mean of 232 parasites) for P. megistus, 52.9%
(128 parasites) for R. prolixus, 47.1% (76 parasites)
for T. vitticeps, 44.4% (106 parasites) for T. infestans,
and 29.4% (98 and 51 parasites respectively) for T.
sordida and T. pseudomaculata. This indicated that P.
megistus, R. neglectus, R. prolixus and T. infestans had
Fig. 1: palm trees habitat of triatomines and opossum infected with Try-
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high vector efficiency, while the other species studied
had lower efficiency. In an exhaustive and detailed ex-
perimental study seeking the best insect for xenodiag-
nosis, among nine triatomine species, it was found that
P. megistus was the most efficient for such tests. Sig-
nificant differences between the percentages of the
forms of T. cruzi in the intestines of the different spe-
cies were also found (Szumlewicz & Müller 1979, 1982,
1987). On the other hand, it was demonstrated (Soares
& Marsden 1986) that T. cruzi was only capable of pen-
etrating through the bite site in 24% of the animals
(mice). It could finally be concluded that the chances of
natural infection of humans by T. cruzi would not be very
high if it were not for the long and intense contact with
infected triatomines that is accumulated over the course
of life, with hundreds of opportunities, from which one
such contact might lead to infection.
Other infection mechanisms such as blood transfu-
sion, consumption of infected material (including breast
milk), and accidental infection in laboratories will not
be discussed here because of space requirements.
The mechanisms for transmitting Chagas infection
can be summarized as follows (Coura et al. 2007):
Principal mechanisms
· By vectors (triatomines)
· By blood transfusion
· Orally (contaminated food)
· Across the placenta or through the birth canal
Secondary mechanisms
· Laboratory accidents
· Handling infected animals
· Organ transplantation
· Sexually (wounds, sperm or menstrual fluids)
· Criminally induced infection by inoculation or orally.
Determinants of Chagas disease
The determinants of Chagas disease result from the
quantity of parasites in the initial infection; the infect-
ing forms in the initial inoculum (number of trypo-
mastigotes); the lineage of T. cruzi inoculated (I, II, Z3
or hybrid Z1/Z3); reinfection; the quality of the strains
and clones (biodema); the specific clonal-histotropic
receptors of the host; and the patient’s initial and late
immune response (Coura 1988, Macedo & Pena 1998,
Andrade et al. 2006, Teixeira et al. 2006).
The parasites deposited on skin wounds or mucosa
stimulate a local inflammatory reaction (inoculation
chagoma or Romaña’s sign) with a lymphoreticular re-
sponse. The circulating trypomastigotes enveloped by
macrophages are taken to the liver, spleen, lymphatic
ganglia, and skeletal and cardiac muscles to form
pseudocysts of amastigotes. With the rupture of the
pseudocysts in the myocardium or myenteric plexuses,
acute myocarditis mediated by TCD4+ and TCD8+ cells
and interleukins (mainly IL-2 and IL-4) occurs. The in-
flammatory reaction leads to muscle and neuron cell
destruction, which is maintained by the presence of T.
cruzi or its fragments and by the DNA of the parasite,
Fig. 2a: trypomastigotes circulating in blood during acute phase; b: pseudocysts of amastigotes in myocardial fibers in the acute phase of Chagas
disease; c: fibrosis of the myocardial conducting system in chronic phase of Chagas disease; d: hipertrophy of myocardium and dilatation of the heart
cavities with the presence of thrombi in chronic Chagas heart disease (Coura et al. 2007).
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with a late hypersensitivity reaction, dilatation of the
microcirculation and fibrosis, thus inducing dilated
chronic myocardiopathy, arrhythmia, dysperistalsis, me-
gaesophagus, and megacolon. Fig. 2 shows T. cruzi and
the lesions that it causes in the heart.
Three characteristics of the presentation of Chagas
disease need to be discussed here: the acute or initial
phase; the chronic phase with its indeterminate, cardiac,
and digestive (enlarged) forms; and the congenital form,
which presents particular characteristics.
Among the determinants of Chagas disease, the fol-
lowing need to be considered: the inoculum of T. cruzi
in the initial infection and the opportunities for reinfec-
tion; the biological characteristics of the infecting strains
and clones, and particularly their histotropism; and the
host response at cell and humoral level.
The inoculum in the initial infection is expected to
be a factor of great importance in the development of
Chagas disease. All the indications from experimental
studies are that this inoculum is generally small. In one
experimental study (Borges-Pereira et al. 1988), a mean
range of 51 to 276 T. cruzi per defecation was found in a
study on eight species of infected triatomines, although
sometimes single defecations containing more than 1500
parasites were found. Even so, the natural inoculum is
infinitely smaller than what is used experimentally on
laboratory animals, which reaches 10,000 parasites or
more for one mouse.
The vast majority of cases of the acute or initial form
of Chagas disease in Brazil present few or no symptoms,
possibly because of the small inoculum. Among 510
chronic cases in several Brazilian states that we followed
up over the last 30 years, we found that less than 1% had
a history of an acute phase (Coura et al. 1983). A study
following up 544 individuals who were exposed to natu-
ral infection by T. cruzi over a 16-month period, it was
found that 14 (2.57%) became infected, of whom only
one third presented symptoms compatible with the acute
phase of the disease (Teixeira 1997). On the other hand,
a study covering almost three decades of following up
cases with a known acute phase, in the municipality of
Bambuí, found that the most severe chronic cases origi-
nated from cases that have had a severe acute form. From
this, it could be inferred that the initial inoculum and/or
the infecting strain of T. cruzi had an influence on the
evolution of the disease (Dias 1982).
Reinfection by T. cruzi is expected to be rare because
of the concomitant immunity induced by the primary in-
fection. Nonetheless, its existence has already been
proven both experimentally and in human cases. A wide-
ranging study on the “influence of exposure to reinfec-
tion on the evolution of Chagas disease” has even de-
scribed a case of proven reinfection that led to death
during the acute phase (Macedo 1976).
The biological characteristics of the strains and
clones of T. cruzi, and particularly its tissue tropism,
certainly have an important function as determinants of
Chagas disease and its clinical form. Different strains
of T. cruzi have been grouped according to their bio-
logical characteristics and cell tropism in mice, to cre-
ate three characteristic groups (Andrade 1976). In an-
other study, it was found that clones from the same strain
produced lesions of differing intensities experimentally
(Postan et al. 1983). In a study under our guidance, it
was seen that there was a lack of correlation between
experimental histopathological findings from mice and
17 strains of T. cruzi that were isolated from patients
with different clinical forms of human Chagas disease
(Schlemper et al. 1983).
Two pathogenic mechanisms are known for infection
by T. cruzi: the first, described by Gaspar Vianna in 1911,
consists of a local inflammatory reaction with necrosis,
tissue destruction, and scar formation with fibrosis; the
second, which is more complex to understand and prove,
is the immunological mechanism or mechanisms (Tei-
xeira et al. 1975, Andrade 1999). However, this auto-
immunity is insufficient to explain all the pathogenesis
of Chagas disease (Tarleton 2003). Sensitization of
TCD4+ and TCD8+ lymphocytes by T. cruzi, with the de-
velopment of anti-myocardial cells, associated with mi-
gration and activation of macrophages and the release of
platelet aggregation factors, thereby respectively induc-
ing chronic Chagas myocarditis and myocardial ischemic
lesions, may explain the findings encountered in cases
of chronic Chagas cardiopathy (Higushi 1999). On the
other hand, the neuron destruction in the heart, esopha-
gus, colon, and other hollow viscera may be explained
both by direct inflammatory phenomena and by immu-
nological mechanisms that result in the cardiopathy,
megaesophagus, megacolon, and other enlargement phe-
nomena seen in Chagas disease (Prata 2001, Teixeira et
al. 2006).
The lesions of the acute phase of the disease are char-
acterized by the presence of localized inflammatory re-
actions, with predominance of mononuclear cells at the
foci of the pseudocyst ruptures, occasionally with the
formation of granulomas located mainly in muscle and
cardiac tissue. In certain cases, there may be lympho-
reticular hyperplasia in the lymphatic ganglia, liver, and
spleen and the presence of macrophages invaded by para-
sitic cells. In other cases, or concomitantly, there may
be diffuse acute myocarditis, with interstitial edema,
hypertrophy of myocardial fibers, and dilatation of car-
diac cavities. The destruction of the cardiac neurons and
myenteric plexuses, with reductions in the numbers of
neurons, begins in the acute phase and continues in the
chronic phase of the disease (Koberle 1961, Andrade
2000, Andrade 2005) (Fig. 3: evolutive schedule of Chagas
heart disease; adapted from Higushi 1999).
The indeterminate chronic phase (asymptomatic) has
practically no anatomopathological translation, except
for occasional isolated inflammatory foci in the myo-
cardium and a limited reduction in the numbers of car-
diac neurons and myenteric plexuses that is insufficient
to produce clinical manifestations (Andrade et al. 1997).
On the other hand, in the cardiac form of the chronic
phase, there may be extensive myocardial fibrosis, de-
struction of the conduction system, and a large reduc-
tion in the numbers of cardiac neurons. It is worth point-
ing out that, in these cases, isolated foci of acute in-
flammatory reaction are occasionally present, as if this
were a reactivation of the process. In chronic Chagas117 Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 102(Suppl. I), 2007
cardiopathy cases, it is common to find hypertrophy of
myocardial fibers and dilatation of the cavities, with the
presence of thrombi, fibrosis, and thinning of the ven-
tricular apices, particularly in the left ventricle. These
are sometimes characterized as true apical aneurysms
and are almost always internally carpeted with organized
blood thrombi. Also in the chronic phase, there is fre-
quently a large reduction in the number of neurons in
the myenteric plexuses, particularly in the esophagus and
colon, which leads to dysperistalsis and dilatation of
these organs that is characterized by megaesophagus,
megacolon, and other enlargements of hollow viscera
such as the bladder, ureter, gallbladder, and other less
common examples (Andrade & Andrade 1966, Lopes &
Chapadeiro 1997, Dias & Macedo 2005).
The congenital form of Chagas disease seems to oc-
cur solely in pregnant women who have a lesion in the
placenta that favors penetration by T. cruzi as far as the
chorionic villi, where amastigote forms multiply (prob-
ably in Hofbauer cells) and subsequently invade the fetal
circulation (Bittencourt 1963, Carlier & Torrico 2005).
Clinical phases and forms: morbidity-mortality
Chagas disease presents an initial or acute phase with
evident parasitemia seen in direct examination of the
blood. In most cases there are no symptoms, but in symp-
tomatic cases there are entry point signs (inoculation
chagoma or Romaña’s sign (Fig. 4), with fever, general-
ized adenopathy, edema, hepatosplenomegaly, myocardi-
tis, and meningoencephalitis in severe cases. This is fol-
lowed by a chronic phase that in most cases presents as
an indeterminate form (asymptomatic, with normal re-
sults from electrocardiogram and x-ray of the heart,
esophagus, and colon), which may evolve to the cardiac
or digestive form (megaesophagus and megacolon), or
cardiac and digestive forms together. The so-called con-
genital form mentioned earlier may also occur, by means
of transmission across the placenta or through the birth
canal during delivery, and this may give rise to abortion,
Fig 3: evolutive schedule of pathogenesis of Chagas heart disease (adapted from Higushi 1999).
Acute Trypanosoma cruzi infection
Hyperergic immune response
Persistence of many
parasites in the host
(immunodepression of the host)
Periodic recirculation of the
parasite
Strong delayed hypersensitive
response
Dilated microcirculation
ischemic lesions due to
steal phenomenon and low
perfusion in border zones
Myocardial aneurism and
SA and AV nodes injuries
Arrhythmia Sudden death
Adequate immune
response
Low number of parasites
remaining in the host
Weak delayed hypersensi-
tive response
Weak inflammation,
hypertrophy or fibrosis of
the myocardium
Indeterminate form
Chronic phase of Chagas
disease
Extracellular matrix alterations
Ventricular dilation
Chronic heart failure
Myocarditis
and
fibrosis
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prematurity or organic lesions in the fetus (Bittencourt
1963, Carlier & Torrico 2005). In cases with immuno-
suppression, the chronic infection may become acute
again, thereby producing diffuse myocarditis, lesions of the
central nervous system, and severe meningoencephalitis.
The clinical phases and forms of Chagas disease can
be summarized as follows (Coura et al. 2007):
Acute phase
· Asymptomatic form
· Moderate form
· Severe form
Chronic phase
· Indeterminate form
· Cardiac form
· Digestive form
· Mixed form (cardiac and digestive)
· Neuroautonomic form
Congenital form
· Abortion
· Prematurity
· Organic lesions in the fetus
Forms in immunosuppressed individuals
· Evident parasitemia
· Lesions of the central nervous system
· Diffuse myocarditis and meningoencephalitis.
Fig. 4: acute case described by Carlos Chagas as Fot. n.1 (Mem Inst
Oswaldo Cruz 8: 37-60, 1916).
In the chronic phase, Chagas infection may present
as an indeterminate form, in which approximately 40%
of the infected individuals remain totally asymptomatic,
with anatomically and physiologically normal x-ray re-
sults for the heart, esophagus, and colon and no changes
seen on electrocardiograms. Although they are asymp-
tomatic, these patients present positive serological re-
actions for T. cruzi infection and, for many of these pa-
tients, the xenodiagnosis and PCR results may be repeat-
edly positive for many years. Thus, they display a veri-
table equilibrium between the parasite and host. There is
great regional variation in the morbidity of Chagas dis-
ease. The indeterminate form can vary from 40 to 90%
of the cases (Coura et al. 1985, 1999) (Fig. 5).
The chronic cardiac form is the most expressive
manifestation of Chagas disease, both because of its fre-
quency and because of its severity. It generally appears
between the second and fourth decades of life, five to
fifteen years after the initial infection. The signs and
symptoms of chronic Chagas cardiopathy result from
arrhythmia, cardiac insufficiency, auricular-ventricular
and branch blockages, and thromboembolism. In our first
series of 100 cases studied (Coura 1965), we found the
following manifestations: effort dyspnea 65%, palpita-
tions 54%, extrasystole 51%, apical systolic murmur
47%, vertigo and/or fainting 37%, lower-limb edema
35%, precordial pain 37%, double second heart sound
at the pulmonary focus 24%, hepatomegaly 19%, double
first heart sound at the mitral focus 18%, bradycardia
Fig. 5: distribution by clinical forms and ages of 510 cases of chronic
Chagas disease (Coura et al. 1983).119 Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 102(Suppl. I), 2007
17%, tachycardia 15%, hypophonesis of the heart sounds
10%, gallop rhythm 6%, anasarca 6%, and convulsions
5%. Fig. 6 shows the increased area of the heart and the
electrocardiographic abnormalities in chronic Chagas
cardiopathy.
In the chronic digestive form of the disease, the clini-
cal manifestations result from dysperistalsis of the
esophagus and colon caused by destruction of the my-
enteric plexuses, which consequently leads to megae-
sophagus and megacolon. Although isolated cases of au-
tonomic disorders of the esophagus have been described
in the acute phase of the disease, these occur mostly in
the chronic phase, when the dysperistalsis and spasms
are accompanied by enlargement of the esophagus. Fig.
7 shows the evolution of megaesophagus and Fig. 8 the
megacolon.
The prognosis for Chagas disease depends on the
clinical form and the complications during its evolution.
In the acute phase, it depends on the patient’s age and the
severity and location of the lesions. In general, the acute
phase is very severe among children less than two years
old, and it is almost always fatal in those with myocardi-
tis, cardiac insufficiency, and meningoencephalitis. The
prognosis may also be very poor in the congenital form,
which may lead not only to abortion and prematurity but
also to organic lesions in the liver, spleen, heart, and
central nervous system, with neurological sequelae and
mental deficiency. Many cases may be asymptomatic and
remain in the indeterminate form.
In the chronic cardiac form, the prognosis varies con-
siderably from one case to another. Patients with mini-
mal lesions such as blockage of the right branch alone
or unifocal ventricular or auricular extrasystole tend to
remain stable and most of them survive for long periods
and often end up dying for other reasons. Patients with
complex arrhythmia, multifocal extrasystole, paroxystic
tachycardia, auricular fibrillation, third-degree A-V
blockage or cardiac insufficiency have a very poor prog-
nosis. A third group of patients with slightly increased
heart area and changeable electrocardiographic findings
and clinical manifestations have an uncertain prognosis
(Nogueira & Coura 1990).
Studies carried out by our group (Abreu 1977, Coura
et al. 1985, Borges Pereira et al. 1985) in field areas in
Minas Gerais have shown that the mortality due to Chagas
cardiopathy increases progressively from 30 to 59 years
of age. In these studies, we showed that the death rate
due to Chagas cardiopathy was 8.9% among patients fol-
lowed up for six years and 17% in another group fol-
lowed up for ten years. These same authors found that
sudden death occurred in two thirds of the cases, while
the other third died because of cardiac insufficiency. The
prognosis for the digestive and indeterminate forms is
generally good, except in cases of the digestive form
with complications (esophageal cancer, obstruction with
twisting, and colon necrosis). None of the cases of the
digestive or indeterminate form that we observed over
six and ten-year periods progressed to death (Coura &
Borges Pereira 1984).
Chagas disease in the Amazon region
Several acute cases of human Chagas disease have
been reported from the Amazon region most of them by
T. curzi I, Z3, and hibrid ZI/Z3. In the localities where
this disease has been reported, the chronic form of this
disease is considered to present low endemicity. The first
acute cases in the Amazon region were reported by Floch
and Tasque (1941) and by Floch and Camain (1948) from
Fig. 6a: r-x showing enlargement of heart in chronic Chagas cardiomiopathy; b: ECG showing ventricle extrasystoles, A-
V block, schemia, and myocardial fibrosis in chronic Chagas heart disease (Albajar et al. 2003).
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French Guiana. Shaw et al. (1969) described another four
acute cases in Belém, the capital of the state of Pará, in
Northern Brazil. Since then, more than four hundred acute
cases have been reported, most of them from outbreaks
probably by oral transmission in the states of Pará, Amapá,
and Amazonas, Brazil (Valente &Valente 1993, Valente et
al. 1999, Pinto et al 2004, Coura 2006). Serological sur-
veys and cross-sectional studies carried out by Fundação
Nacional de Saúde from 1975 to 1980 in different states
in the Brazilian Amazon region and by Coura et al. from
1971 to 2002 in the state of Amazonas showed preva-
lences ranging from 2.4% to 13.2% (Camargo et al.
1984, Coura et al. 1999, 2002). Sporadic chronic cases of
Chagas disease have also been reported from the Brazilian
Amazon region (Albajar et al. 2003, Junqueira et al. 2005,
Xavier et al. 2006).
The ten top Chagas disease needs
1. To clarify the pathogenesis and evolutive pattern
of Chagas disease.
2. To develop an effective drug for the acute and
chronic phases.
3. To improve a specific and fast test for T. cruzi I, II,
Z3, and Z1/Z3 infections.
4. To standardize the techniques for serological di-
agnosis and control of cure evaluation.
5. To compare the morbidity induced by the four
types of T. cruzi.
6. To study the metacyclogenesis of different strains
of T. cruzi.
7. To analyze the risk that wild triatomines may be-
come adapted to human dwellings.
8. To evaluate the morbidity of Chagas disease in the
Amazon region.
9. To establish a surveillance and control program
for Chagas disease in the Amazon region.
10. To prioritize Chagas disease control programs in
Latin America and Mexico.
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